Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor

Experimental Neurology

Volumn 160, Issue 1, 1999, Pages 289-299

  Veerhuis, Robert ^a   Janssen, Ingrid ^a   De Groot, Corline J A ^a   Van Muiswinkel, Freek L ^a   Hack, C Erik ^b   Eikelenboom, Piet ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

Alzheimer's disease; Astrocytes; C1, C1 inhibitor; Complement; Microglia

Indexed keywords

AMYLOID; COMPLEMENT COMPONENT C1S INHIBITOR; INTERLEUKIN 1; INTERLEUKIN 6; PROTEIN DERIVATIVE; TUMOR NECROSIS FACTOR;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL CULTURE; CELL STIMULATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROGLIA; NERVE CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; SENILE PLAQUE;

EID: 0032710620     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7199     Document Type: Article

References (51)

1. Akiyama H., Ikeda K., Kondo H., McGeer P. L. Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci. Lett. 146:1992;152-154.
2. Alley M. C., Scudiero D. A., Monks A., Hursey M. L., Czerwinski M. J., Fine D. L., Abbott B. J., Mayo J. G., Shoemaker R. H., Boyd M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture terazolium assay. Cancer Res. 48:1988;589-601.
3. Barnum S. R., Jones J. L., Benveniste E. N. Interleukin-1 and tumor necrosis factor-mediated regulation of C3 gene expression in human astroglioma cells. Glia. 7:1993;225-236.
4. Barnum S. R. Complement biosynthesis in the central nervous system. Crit. Rev. Oral Biol. Med. 6:1995;132-146.
5. Bensa J. C., Reboul A., Colomb M. G. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes. Biochem. J. 216:1983;385-392.
6. Bergamaschini L., Parnetti L., Pareyson D., Canziani S., Cugno M., Agostoni A. Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease. Alzheimer Dis. Relat. Disord. 12:1998;102-108.
7. Bradley K., North J., Saunders D., Schwaeble W., Jeziorska M., Woolley D. E., Whaley K. Synthesis of classical pathway complement components by chondrocytes. Immunology. 88:1996;648-656.
8. Cavanaugh K. P., Gurwitz D., Cunningham D. D., Bradshaw R. A. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J. Neurochem. 54:1990;1735-1743.
9. Colten H. R., Strunk R. C. Synthesis of complement components in liver and at extrahepatic sites. Whaley K., Loos M., Weiler J. Complement in Health and Disease. 1993;127-158 Kluwer Academic, Amsterdam.
10. De Groot C. J. A., Langeveld C. H., Jongenelen C. A. M., Montagne E. J., Van der Valk P., Dijkstra C. D. Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: Immunophenotypical and functional characterization. J. Neurosci. Res. 49:1997;342-354.
11. De Smet B. J. G. L., De Boer J.-P., Agterberg J., Rigter G., Bleeker W. K., Hack C. E. Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats. Blood. 81:1994;56-61.
12. Dickson D. W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56:1997;321-339.
13. Eikelenboom P., Stam F. C. Immunoglobulins and complement factors in senile plaques. Acta Neuropathol. 57:1982;239-242.
14. Eikelenboom P., Hack C. E., Rozemuller J. M., Stam F. C. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. B. 56:1989;259-262.
15. Eikelenboom P., Rozemuller J. M., Kraal G., Stam F. C., McBride P. A., Bruce M. E., Fraser H. Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch. B. 60:1991;329-336.
16. Eikelenboom P., Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging. 17:1996;673-680.
17. Gasque P., Ischenko A., Legoedec J., Mauger C., Schouft M.-T., Fontaine M. Expression of the complement classical pathway by human glioma in culture. J. Biol. Chem. 268:1993;25068-25074.
18. Gasque P., Thomas A., Fontaine M., Morgan B. P. Complement activation on human neuroblastoma cell lines in vitro: Route of activation and expression of functional complement regulatory proteins. J. Neuroimmunol. 66:1996;29-40.
19. Gasque P., Chan P., Mauger C., Schouft M.-T., Singhrao S., Dierich M. P., Morgan B. P., Fontaine M. Identification and characterization of complement C3 receptors on human astrocytes. J. Immunol. 156:1996;2247-2255.
20. Gasque P., Singhrao S., Neal J. W., Götze O., Morgan B. P. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150:1997;31-41.
21. Griffin W. S. T., Sheng J. G., Roberts G. W., Mrak R. E. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54:1995;276-281.
22. Gulati P., Lemercier C., Guc D., Lappin D., Whaley K. Regulation of the synthesis of C1 subcomponents and C1-inhibitor. Behring Inst. Mitt. 93:1993;196-203.
23. Haga S., Ikeda K., Sato M., Ishii T. Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601:1993;88-94.
24. Hays S. J., Caprathe B. W., Gilmore J. L., Amin N., Emmerling M. R., Michael W., Nadimpalli R., Nath R., Raser K. J., Stafford D., Watson D., Wang K., Jaen J. C. 2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease. J. Med. Chem. 41:1998;1060-1067.
25. Ishii T., Haga S. Immuno-electron microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol. 63:1984;296-300.
26. Jiang H., Burdick D., Glabe C., Cotman C. W., Tenner A. J. β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152:1994;5050-5059.
27. Kilchherr E., Fuchs H., Tschopp J., Engel J. Dissociation of C1 and concentration dependence of its activation kinetics. Mol. Immunol. 19:1982;683-691.
28. Korotzer A. R., Watt J., Cribbs D., Tenner A. J., Burdick D., Glabe C., Cotman C. W. Cultured rat microglia express C1q and receptor for C1q: Implications for amyloid effects on microglia. Exp. Neurol. 134:1995;214-221.
29. Lampert-Etchells M., Pasinetti G. M., Finch C. E., Johnson S. A. Regional localization of cells containing complement C1q and C4 mRNAs in the frontal cortex during Alzheimer's disease. Neurodegeneration. 2:1993;111-121.
30. Loos M. Biosynthesis of the collagen-like C1q molecule and its receptor for Fc and polyanionic molecules on macrophages. Cooper M., Hofschneider P. H., Koprowski H., Melchers F., Rott R., Schweger H. G., Vogt P. K., Zinkernagel R. Current Topics in Microbiology and Immunology. 1983;1-56 Springer-Verlag, Heidelberg.
31. Lue L.-F., Brachova L., Waker D. G., Rogers J. Characterization of glial cultures from rapid autopsies of Alzheimer's and control patients. Neurobiol. Aging. 17:1996;421-429.
32. McGeer P. L., Akiyama H., Itagaki S., McGeer E. G. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16:1989;516-527.
33. McComb R. D., Miller K. A., Carson S. D. Tissue factor antigen in senile plaques of Alzheimer's disease. Am. J. Pathol. 139:1991;491-494.
34. Monard D., Niday E., Limat A., Solomon F. Inhibition of protease activity can lead to neurite extension in neuroblastoma cells. Prog. Brain Res. 163:1983;359-364.
35. Nuijens J. H., Huijbregts C. C. M., van Mierlo G. M., Hack C. E. Inactivation of C1 inhibitor by proteases: demonstration by a monoclonal antibody of a neodeterminant on inactivated, non-complexed C1 inhibitor. Immunology. 61:1987;387-389.
36. Pasinetti G. M., Johnson S. A., Rozovsky I., Lampert-Etchells M., Morgan D. G., Gordon M. N., Willoughby D., Finch C. E. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp. Neurol. 118:1992;117-125.
37. Ponsoda X., Jover R., Castell J. V., Gomez-Lechon M. J. Measurement of intracellular LDH activity in 96-well cultures: A rapid and automated assay for cytotoxicity studies. J. Tissue Culture Methods. 13:1991;21-24.
38. Rogers J., Cooper N. R., Webster S., Schultz J., McGeer P. L., Styren S. D., Civin W. H., Brachova L., Bradt B., Ward P., Lieberburg I. Complement activation by β-amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 89:1992;10016-10020.
39. Rozemuller J. M., Eikelenboom P., Pals S. T., Stam F. C. Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci. Lett. 101:1989;288-292.
40. Sakiyama H., Inaba N., Toyoguchi T., Okada Y., Matsumoto M., Moriya H., Ohtsu H. Immunolocalization of complement C1s and matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase) in the primary ossification center of the human femur. Cell Tissue Res. 277:1994;239-245.
41. Shen Y., Li R., McGeer E. G., McGeer P. L. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 769:1997;391-395.
42. Snyder S. W., Wang G. T., Barrett L., Ladror U. S., Casuto D., Lee C. M., Krafft G. A., Holzman R. B., Holzman T. F. Complement C1q does not bind to monomeric β-amyloid. Exp. Neurol. 128:1994;136-142.
43. Spiegel, K., M. R. Emmerling, and S. R. Barnum. 1997. Strategies for inhibition of complement activation in the treatment of neurodegenerative diseases. In Neuroinflammation: Mechanisms and ManagementP. L. Wood, Ed., Chap. 5, pp. 129-176. Humana Press, Totowa, NJ.
44. Toyoguchi T., Yamaguchi K., Nakagawa K., Fukusawa T., Moriya H., Sakiyama H. Change of complement C1s synthesis during development of hamster cartilage. Cell Tissue Res. 285:1996;199-204.
45. Veerhuis R., Janssen I., Hack C. E., Eikelenboom P. Early complement components in Alzheimer's disease brains. Acta Neuropathol. 91:1996;53-60.
46. Veerhuis R., Janssen I., Hoozemans J. J. M., De Groot C. J. A., Hack C. E., Eikelenboom P. Complement C1-inhibitor expression in Alzheimer's disease. Acta Neuropathol. 96:1998;287-296.
47. Walker D. G., McGeer P. L. Complement gene expression in human brain: Comparison between normal and Alzheimer disease cases. Mol. Brain Res. 14:1992;109-116.
48. Walker D. G., Yasuhara O., Patston P. A., McGeer E. G., McGeer P. L. Complement C1 inhibitor is produced by human brain tissue and is cleaved in Alzheimer disease. Brain Res. 675:1995;75-82.
49. Yasuhara O., Walker D. G., McGeer P. L. Hageman factor and its binding sites are present in senile plaques of Alzheimer's disease. Brain Res. 654:1994;234-240.
50. Yong V. W., Antel J. P. Culture of glial cells from human brain biopsies. Fedoroff S., Richardson A. Protocols for Neuronal Cell Culture. 1992;81-96 Humana Press, Totowa.
51. Ziccardi R. J., Cooper N. R. Active disassembly of the first complement component, C1, by C1 inactivator. J. Immunol. 123:1979;788-792.